384 related articles for article (PubMed ID: 36187919)
1. Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.
Liu W; Liu C; Wang H; Xu L; Zhou J; Li S; Cheng Y; Zhou R; Zhao L
Comput Struct Biotechnol J; 2022; 20():5150-5161. PubMed ID: 36187919
[TBL] [Abstract][Full Text] [Related]
2. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J; Huang T; Deng Z; Zou C
Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
[TBL] [Abstract][Full Text] [Related]
3. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors.
Tong H; Wei H; Smith AO; Huang J
Front Immunol; 2021; 12():802049. PubMed ID: 35069586
[TBL] [Abstract][Full Text] [Related]
4. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
Zhou X; Li C; Chen T; Li W; Wang X; Yang Q
Mol Cancer; 2023 Feb; 22(1):36. PubMed ID: 36810108
[TBL] [Abstract][Full Text] [Related]
5. Targeting RNA N
Li W; Hao Y; Zhang X; Xu S; Pang D
Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
[TBL] [Abstract][Full Text] [Related]
6. The regulation of N6-methyladenosine modification in PD-L1-induced anti-tumor immunity.
Yu W; Lin J; Yu T; Lou J; Qian C; Xu A; Liu B; Tao H; Jin L
Immunol Cell Biol; 2023 Mar; 101(3):204-215. PubMed ID: 36630591
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
8. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
Gu J; Bi F
Front Genet; 2021; 12():671179. PubMed ID: 34306015
[TBL] [Abstract][Full Text] [Related]
9. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
Front Oncol; 2022; 12():970833. PubMed ID: 36226062
[TBL] [Abstract][Full Text] [Related]
10. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
11. RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Li H; Hu J; Yu A; Othmane B; Guo T; Liu J; Cheng C; Chen J; Zu X
Front Oncol; 2021; 11():642159. PubMed ID: 33816290
[TBL] [Abstract][Full Text] [Related]
12. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.
Sun X; Wang H; Pu X; Wu Y; Yuan X; Wang X; Lu H
Cancer Gene Ther; 2024 Jun; ():. PubMed ID: 38834772
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
[No Abstract] [Full Text] [Related]
15. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Huang X; Qiu Z; Li L; Chen B; Huang P
Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
Front Genet; 2021; 12():790888. PubMed ID: 34976022
[TBL] [Abstract][Full Text] [Related]
17. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.
Xia Z; Kong F; Wang K; Zhang X
Front Pharmacol; 2022; 13():908079. PubMed ID: 35754499
[TBL] [Abstract][Full Text] [Related]
18. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
Luo Y; Sun X; Xiong J
Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
[No Abstract] [Full Text] [Related]
19. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
20. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
